Dover is extending its presence in the biopharma market by entering into a definitive agreement to acquire Em-tec GmbH, a German designer and manufacturer of flow measurement devices.

Em-tec has a 30-year history of producing flow measurement equipment used in connection with cardiac, vascular and transplant surgery, dialysis and life support procedures, automated bioprocess monitoring, and laboratory and industrial processes where flexible tubing is used.

The German company will become part of the PSG business unit within Dover’s Pumps & Process Solutions segment.

The addition of Em-tec further expands Dover’s reach into biopharma and other hygienic applications and enhances its portfolio of flow control technologies with flow rate sensors.

“We are excited to bring together Em-tec’s flow measurement devices and PSG’s Quattroflow pump technology to expand our offering to our customers in biopharma and medical applications,” said Richard Tobin, Dover’s president and CEO.